ArticlebioRxiv : the preprint server for biology2026

Engineered subtilisin protease degrades active KRAS in cancer cells, leading to differential cell targeting.

M E Goldstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.